Evidence Synthesis
Vadilinx sees a standard shift in the market, driven by accelerating metrics in revenue growth, gross margin, and marginal operating leverage.
Loading stock analysis…
Loading stock analysis…
Evidence Synthesis
Last synthesized: 5 Sept 2026, 08:21
See how this stock's evidence score moved across recent sessions — unlock Pro for the live chart.
Full momentum history unlocks with Pro or Research.
Evidence Synthesis
Vadilinx sees a standard shift in the market, driven by accelerating metrics in revenue growth, gross margin, and marginal operating leverage.
Source observations behind the synthesis narrative.
| Metric | Value | Trend | |
|---|---|---|---|
| GROSS_MARGIN | 19.15 % | 4.54 | ▲ |
| MARGINAL_OPERATING_LEVERAGE | 4.54 % | -0.09 | ▲ |
| REVENUE_GROWTH_YOY | 36.2 % | 15.9 | ▲ |
| PRICE_CHANGE_PERCENT | -2.739 % | — | - |
| DAILY_VOLUME | 550 shares | 107 | ▲ |
| CLOSE_PRICE | 10,163.75 INR | 10,450 | ▼ |